ImCare Biotech has been awarded Phase II grant by NCI (NIH) for its project on development of a diagnostic kit for early detection of liver cancer.
ImCare Biotech has been awarded SBIR grant by NCI (NIH) (National Cancer Institute) to develop its diagonistic kit Seravue® for early detection of liver cancer (HCC and ICC) on 9/2012.
COMPANY EVENTS PRODUCTS
